急性呼吸衰竭患者支气管肺泡灌洗液淋巴细胞计数的预后价值:一项回顾性队列研究
这项单中心回顾性观察研究纳入2015年4月至2018年5月在日本一所大学医院因肺部浸润和急性呼吸衰竭接受支气管肺泡灌洗的连续患者78例,随访至少1年,主要分析为1年死亡率的ROC-AUC。幸存者(56例)较非幸存者(22例)灌洗液淋巴细胞和嗜酸性粒细胞计数显著升高、中性粒细胞计数显著降低,其中淋巴细胞计数差异最显著(30% [12-50] vs. 7.0% [2.9-13],P<0.0001)。灌洗液淋巴细胞预测1年死亡的AUC为0.787(P<0.0001,约登指数界值19.0%),≥20%与调整基线不平衡后1年生存率升高相关(调整HR 0.0929,95%CI 0.0147-0.323,P<0.0001;90天P=0.0012),在间质性肺病和非间质性肺病亚组中均显著(P=0.0052和P=0.0033)。
要点
- 急性呼吸衰竭患者灌洗液淋巴细胞≥20%与1年死亡率降低独立相关(调整HR 0.0929,95%CI 0.0147-0.323,P<0.0001)。
- 灌洗液淋巴细胞预测1年死亡的AUC为0.787(P<0.0001),约登指数界值为19.0%。
- 幸存者灌洗液淋巴细胞中位数30%(12-50)显著高于非幸存者7.0%(2.9-13),P<0.0001。
- ≥20%灌洗液淋巴细胞者在间质性肺病(P=0.0052)和非间质性肺病(P=0.0033)亚组中均与生存率升高相关。
- ≥20%灌洗液淋巴细胞者无呼吸机天数显著增多,提示呼吸功能障碍更轻。
适用人群与场景
- 日本一所大学医院因肺部浸润和急性呼吸衰竭接受支气管肺泡灌洗检查的连续患者78例,于2015年4月至2018年5月纳入,随访至少1年。
诊断标准与关键阈值
- 灌洗液淋巴细胞百分比预测1年死亡的ROC曲线约登指数界值为19.0%,AUC为0.787(P<0.0001)。
研究设计与关键结果
- 回顾性单中心观察研究,最终样本78例,幸存者56例、非幸存者22例;幸存者灌洗液淋巴细胞和嗜酸性粒细胞计数显著升高、中性粒细胞计数显著降低,淋巴细胞差异最显著(30% [12-50] vs. 7.0% [2.9-13],P<0.0001)。
- 灌洗液淋巴细胞预测1年死亡的AUC为0.787(P<0.0001,界值19.0%)。
- ≥20%灌洗液淋巴细胞与调整基线不平衡后1年生存率升高相关(调整HR 0.0929,95%CI 0.0147-0.323,P<0.0001;90天P=0.0012)。
- ≥20%灌洗液淋巴细胞与生存率升高在间质性肺病亚组(P=0.0052)和非间质性肺病亚组(P=0.0033)中均显著相关。
- 次要结局分析中,≥20%灌洗液淋巴细胞者无呼吸机天数显著增多,提示呼吸功能障碍更轻。
证据类型、等级与局限
- 证据类型:回顾性单中心观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急性呼吸衰竭且接受支气管肺泡灌洗的患者中,灌洗液淋巴细胞≥20%可能与90天和1年死亡率更低、无呼吸机天数更多相关,作者认为该指标有预后预测价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cellular patterns in bronchoalveolar lavage fluid (BALF) are used to distinguish or rule out particular diseases in patients with acute respiratory failure (ARF). However, whether BALF cellular patterns can predict mortality or not is unknown. We test the hypothesis that BALF cellular patterns have predictive value for mortality in patients with ARF.
METHODS: This was a retrospective single-center observational study conducted in a Japanese University Hospital. Consecutive patients (n = 78) with both pulmonary infiltrates and ARF who were examined by bronchoalveolar lavage (BAL) between April 2015 and May 2018 with at least 1 year of follow-up were analyzed. Primary analysis was receiver operating characteristic curve-area under the curve (ROC-AUC) analysis for 1-year mortality.
RESULTS: Among the final sample size of 78 patients, survivors (n = 56) had significantly increased lymphocyte and eosinophil counts and decreased neutrophil counts in BALF compared with non-survivors (n = 22). Among the fractions, lymphocyte count was the most significantly different (30 [12-50] vs. 7.0 [2.9-13]%, P <0.0001). In the ROC curve analysis of the association of BALF lymphocytes with 1-year mortality, the AUC was 0.787 (P <0.0001, cut-off value [Youden index] 19.0%). Furthermore, ≥20% BALF lymphocytes were significantly associated with increased survival with adjustment for baseline imbalances (1-year adjusted hazard ratio, 0.0929; 95% confidence interval, 0.0147-0.323, P <0.0001; 90-day P =0.0012). Increased survival was significantly associated with ≥20% BALF lymphocytes in both interstitial lung disease (ILD) and non-ILD subgroups (P =0.0052 and P =0.0033, respectively). In secondary outcome analysis, patients with ≥20% BALF lymphocytes had significantly increased ventilator-free days, which represents less respiratory dysfunction than those with <20% BALF lymphocytes.
CONCLUSIONS: In the patients with ARF, ≥20% lymphocytes in BALF was associated with significantly less ventilatory support, lower mortality at both 90-day and 1-year follow-ups.
参考来源
- Hirasawa Y, Nakada TA, Shimazui T, et al. Prognostic value of lymphocyte counts in bronchoalveolar lavage fluid in patients with acute respiratory failure: a retrospective cohort study. J Intensive Care. 2021. PMID: 33622402. doi:10.1186/s40560-021-00536-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。